Nontypeable Haemophilus influenzae as a Pathogen in Children

Pediatric Infectious Disease Journal

Volumn 28, Issue 1, 2009, Pages 43-48

  Murphy, Timothy F ^a,h   Faden, Howard ^a   Bakaletz, Lauren O ^b   Kyd, Jennelle M ^c   Forsgren, Arne ^d   Campos, Jose ^e   Virji, Mumtaz ^f   Pelton, Stephen I ^g  

^a UNIVERSITY AT BUFFALO   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c CENTRAL QUEENSLAND UNIVERSITY   (Australia)

^d LUND UNIVERSITY   (Sweden)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

^g BOSTON MEDICAL CENTER   (United States)

^h VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

Author keywords

nasopharyngeal colonization; nonencapsulated; Nontypeable Haemophilus influenzae; NTHI; otitis media; vaccine

Indexed keywords

ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PNEUMOCOCCAL PROTEIN D VACCINE; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG; VACCINE;

BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL PNEUMONIA; BIOFILM; CLINICAL TRIAL; CONJUNCTIVITIS; CYSTIC FIBROSIS; FEASIBILITY STUDY; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS MENINGITIS; HUMAN; IMMUNE RESPONSE; INFECTION PREVENTION; NONHUMAN; OTITIS MEDIA; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT INFECTION; RESPIRATORY TRACT INFECTION; REVIEW; SINUSITIS; STREPTOCOCCUS PNEUMONIAE; SYMPTOMATOLOGY; VACCINATION;

ANIMALS; CARRIER STATE; CYSTIC FIBROSIS; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS VACCINES; HUMANS; NASOPHARYNX; OTITIS MEDIA;

EID: 65649084792     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318184dba2     Document Type: Review

References (104)

1. Centers for Disease Control. Progress toward elimination of Haemophilus infiuenzae type b invasive disease among infants and children-United States, 1998-2000. MMWR Morb Mortal Wkly Rep. 2002;51:234-237.
2. Musser JM, Barenkamp SJ, Granoff DM, et al. Genetic relationships of serologically nontypable and serotype b strains of Haemophilus infiuenzae. Infect Immun. 1986;52:183-191.
3. Porras O, Caugant DA, Gray B, et al. Difference in structure between type b and nontypable Haemophilus infiuenzae populations. Infect Immun. 1986; 53:79-89.
4. Murphy TF, Brauer AL, Schiffmacher AT, et al. Persistent colonization by Haemophilus infiuenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170:266-272.
5. Sethi S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000. A state of the art review. Clin Microbiol Rev. 2001;14: 336-363.
6. Ruohola A, Meurman O, Nikkari S, et al. Microbiology of acute otitis media in children with tympanostomy tubes: prevalences of bacteria and viruses. Clin Infect Dis. 2006;43:1417-1422.
7. Arguedas A, Dagan R, Leibovitz E, et al. A multicenter, open label, double tympanocentesis study of high dose cefdinir in children with acute otitis media at high risk of persistent or recurrent infection. Pediatr Infect Dis J. 2006;25:211-218.
8. Kilpi T, Herva E, Kaijalainen T, et al. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J. 2001;20:654-662.
9. Chonmaitree T, Owen MJ, Patel JA, et al. Effect of viral respiratory tract infection on outcome of acute otitis media. J Pediatr. 1992;120:856-862.
10. Faden H, Bernstein J, Stanievich J, et al. Effect of prior antibiotic treatment on middle ear disease in children. Ann Otol Rhinol Laryngol. 1992;101:87-91.
11. Gehanno P, Panajotopoulos A, Barry B, et al. Microbiology of otitis media in the Paris, France, area from 1987 to 1997. Pediatr Infect Dis J. 2001;20: 570-573.
12. Rodriguez WJ, Schwartz RH. Streptococcus pneumoniae causes otitis media with higher fever and more redness of tympanic membranes than Haemophilus infiuenzae or Moraxella catarrhalis. Pediatr Infect Dis J. 1999;18:942-944.
13. Leibovitz E, Satran R, Piglansky L, et al. Can acute otitis media caused by Haemophilus infiuenzae be distinguished from that caused by Streptococcus pneumoniae? Pediatr Infect Dis J. 2003;22:509-515.
14. Leibovitz E, Asher E, Piglansky L, et al. Is bilateral acute otitis media clinically different than unilateral acute otitis media? Pediatr Infect Dis J. 2007;26:589-592.
15. McCormick DP, Chandler SM, Chonmaitree T. Laterality of acute otitis media: different clinical and microbiologic characteristics. Pediatr Infect Dis J. 2007;26:583-588.
16. Arguedas A, Dagan R, Soley C, et al. Microbiology of otitis media in Costa Rican children, 1999 through 2001. Pediatr Infect Dis J. 2003;22:1063-1068.
17. Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J. 2004;23:824-828.
18. Block SL, Hedrick J, Harrison CJ, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J. 2004;23:829-833.
19. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403-409.
20. Faden H. The microbiologic and immunologic basis for recurrent otitis media in children. Eur J Pediatr. 2001;160:407-413.
21. Leibovitz E, Jacobs MR, Dagan R. Haemophilus infiuenzae: a significant pathogen in acute otitis media. Pediatr Infect Dis J. 2004;23:1142-1152.
22. American Speech, Language and Hearing Association. Causes of hearing loss in children 1997-2007.Available at: http://www.asha.org/public/hearing/ disorders/causes.htm.
23. American Academy of Pediatrics. Diagnosis and management of acute otitis media. Pediatrics. 2004;113:1451-1465.
24. World Health Organization. Chronic suppurative otitis media: burden of illness and management options. 2004. Available at: http://www.who.int/pbd/ deafness/activities/hearing-care/otitis-media.pdf.
25. Duffy LC, Faden H, Wasielewski R, et al. Exclusive breastfeeding protects against bacterial colonization and day care exposure to otitis media. Pediatrics. 1997;100:E7.
26. Faden H, Brodsky L, Waz MJ, et al. Nasopharyngeal fiora in the first three years of life in normal and otitis-prone children. Ann Otol Rhinol Laryngol. 1991;100:612-615.
27. Emonts M, Veenhoven RH, Wiertsema SP, et al. Genetic polymorphisms in immunoresponse genes TNF-, IL6, IL10, and TLR4 are associated with recurrent acute otitis media. Pediatrics. 2007;120:814-823.
28. Patel PB, Diaz MC, Bennett JE, et al. Clinical features of bacterial conjunctivitis in children. Acad Emerg Med. 2007;14:1-5.
29. Buznach N, Dagan R, Greenberg D. Clinical and bacterial characteristics of acute bacterial conjunctivitis in children in the antibiotic resistance era. Pediatr Infect Dis J. 2005;24:823-828.
30. Alrawi AM, Chern KC, Cevallos V, et al. Biotypes and serotypes of Haemophilus infiuenzae ocular isolates. Br J Ophthalmol. 2002;86:276-277.
31. Ueda D, Yoto Y. The ten-day mark as a practical diagnostic approach for acute paranasal sinusitis in children. Pediatr Infect Dis J. 1996;15:576-579.
32. Brook I. Bacteriology of acute and chronic frontal sinusitis. Arch Otolaryngol Head Neck Surg. 2002;128:583-585.
33. Finegold SM, Flynn MJ, Rose FV, et al. Bacteriologic findings associated with chronic bacterial maxillary sinusitis in adults. Clin Infect Dis. 2002; 35:428-433.
34. Starner TD, Zhang N, Kim G, et al. Haemophilus infiuenzae forms biofilms on airway epithelia: implications in cystic fibrosis. Am J Respir Crit Care Med. 2006;174:213-220.
35. Muhlebach MS, Stewart PW, Leigh MW, et al. Quantitation of infiammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med. 1999;160:186-191.
36. Abman SH, Ogle JW, Harbeck RJ, et al. Early bacteriologic, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening. J Pediatr. 1991;119:211-217.
37. Rosenfeld M, Gibson RL, McNamara S, et al. Early pulmonary infection, infiammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol. 2001;32:356-366.
38. Campos J, Hernando M, Roman F, et al. Analysis of invasive Haemophilus infiuenzae infections after extensive vaccination against H. infiuenzae type b. J Clin Microbiol. 2004;42:524-529.
39. Dworkin MS, Park L, Borchardt SM. The changing epidemiology of invasive Haemophilus infiuenzae disease, especially in persons -65 years old. Clin Infect Dis. 2007;44:810-816.
40. Heath PT, Booy R, Azzopardi HJ, et al. Non-type b Haemophilus infiuenzae disease: clinical and epidemiologic characteristics in the Haemophilus in-fiuenzae type b vaccine era. Pediatr Infect Dis J. 2001;20:300-305.
41. von Gottberg A, de Gouveia L, Madhi SA, et al. Impact of conjugate Haemophilus infiuenzae type b (Hib) vaccine introduction in South Africa. Bull World Health Organ. 2006;84:811-818.
42. Perdue DG, Bulkow LR, Gellin BG, et al. Invasive Haemophilus infiuenzae disease in Alaskan residents aged 10 years and older before and after infant vaccination programs. JAMA. 2000;283:3089-3094.
43. Erwin AL, Nelson KL, Mhlanga-Mutangadura T, et al. Characterization of genetic and phenotypic diversity of invasive nontypeable Haemophilus infiuenzae. Infect Immun. 2005;73:5853-5863.
44. Faden H, Duffy L, Williams A, et al. Epidemiology of nasopharyngeal colonization with nontypeable Haemophilus infiuenzae in the first 2 years of life. J Infect Dis. 1995;172:132-135.
45. Watson K, Carville K, Bowman J, et al. Upper respiratory tract bacterial carriage in Aboriginal and non-Aboriginal children in a semi-arid area of Western Australia. Pediatr Infect Dis J. 2006;25:782-790.
46. Farjo RS, Foxman B, Patel MJ, et al. Diversity and sharing of Haemophilus infiuenzae strains colonizing healthy children attending day-care centers. Pediatr Infect Dis J. 2004;23:41-46.
47. Barbosa-Cesnik C, Farjo RS, Patel M, et al. Predictors for Haemophilus infiuenzae colonization, antibiotic resistance and for sharing an identical isolate among children attending 16 licensed day-care centers in Michigan. Pediatr Infect Dis J. 2006;25:219-223.
48. Revai K, McCormick DP, Patel J, et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal bacterial colonization during acute otitis media. Pediatrics. 2006;117:1823-1829.
49. Ghaffar F, Muniz LS, Katz K, et al. Effects of large dosages of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus infiuenzae, nonpneumococcal alpha-hemolytic streptococci, and Staphylococcus aureus in children with acute otitis media. Clin Infect Dis. 2002;34:1301-1309.
50. Harabuchi Y, Faden H, Yamanaka N, et al. Nasopharyngeal colonization with nontypeable Haemophilus infiuenzae and recurrent otitis media. J Infect Dis. 1994;170:862-866.
51. Faden H, Duffy L, Wasielewski R, et al. Relationship between nasopharyngeal colonization and the development of otitis media in children. J Infect Dis. 1997;175:1440-1445.
52. St Geme JW III. Molecular and cellular determinants of non-typeable Haemophilus infiuenzae adherence and invasion. Cell Microbiol. 2002;4: 191-200.
53. Avadhanula V, Rodriguez CA, Ulett GC, et al. Nontypeable Haemophilus infiuenzae adheres to intercellular adhesion molecule 1 (ICAM-1) on respiratory epithelial cells and upregulates ICAM-1 expression. Infect Immun. 2006;74:830-838.
54. St Geme JW III, Kumar VV, Cutter D, et al. Prevalence and distribution of the hmw and hia genes and the HMW and Hia adhesins among genetically diverse strains of nontypeable Haemophilus infiuenzae. Infect Immun. 1998; 66:364-368.
55. Swords WE, Chance DL, Cohn LA, et al. Acylation of the lipooligosaccha-ride of Haemophilus infiuenzae and colonization: an htrB mutation diminishes the colonization of human airway epithelial cells. Infect Immun. 2002;70:4661-4668.
56. Fink DL, Buscher AZ, Green B, et al. The Haemophilus infiuenzae Hap autotransporter mediates microcolony formation and adherence to epithelial cells and extracellular matrix via binding regions in the C-terminal end of the passenger domain. Cell Microbiol. 2003;5:175-186.
57. St Geme JW III, Falkow S, Barenkamp SJ. High-molecular-weight proteins of nontypable Haemophilus infiuenzae mediate attachment to human epithelial cells. Proc Natl Acad Sci USA. 1993;90:2875-2879.
58. Gilsdorf JR, Tucci M, Marrs CF. Role of pili in Haemophilus infiuenzae adherence to, and internalization by, respiratory cells. Pediatr Res. 1996; 39:343-348.
59. Barenkamp SJ, St Geme JW III. Identification of a second family of high-molecular-weight adhesion proteins expressed by non-typable Hae-mophilus infieunzae. Mol Microbiol. 1996;19:1215-1223.
60. Reddy MS, Bernstein JM, Murphy TF, et al. Binding between outer membrane proteins of nontypeable Haemophilus infiuenzae and human nasopharyngeal mucin. Infect Immun. 1996;64:1477-1479.
61. Swords WE, Ketterer MR, Shao J, et al. Binding of the non-typeable Haemophilus infiuenzae lipooligosaccharide to the PAF receptor initiates host cell signalling. Cell Microbiol. 2001;3:525-536.
62. Hill DJ, Toleman MA, Evans DJ, et al. The variable P5 proteins of typeable and non-typeable Haemophilus infiuenzae target human CEACAM1. Mol Microbiol. 2001;39:850-862.
63. St Geme JW III. The HMW1 adhesin of nontypeable Haemophilus infiuenzae recognizes sialylated glycoprotein receptors on cultured human epithelial cells. Infect Immun. 1994;62:3881-3889.
64. Bookwalter JE, Jurcisek JA, Gray-Owen SD, et al. A CEACAM1 homologue plays a pivotal role in nontypeable Haemophilus infiuenzae colonization of the chinchilla nasopharynx via the OMP P5-homologous adhesin. Infect Immun. 2008;76:48-55.
65. Ketterer MR, Shao JQ, Hornick DB, et al. Infection of primary human bronchial epithelial cells by Haemophilus infiuenzae: macropinocytosis as a mechanism of airway epithelial cell entry. Infect Immun. 1999;67: 4161-4170.
66. Forsgren J, Samuelson A, Ahlin A, et al. Haemophilus infiuenzae resides and multiplies intracellularly in human adenoid tissue as demonstrated by in situ hybridization and bacterial viability assay. Infect Immun. 1994;62:673-679.
67. Swords WE, Buscher BA, Ver Steeg Ii K, et al. Non-typeable Haemophilus infiuenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor. Mol Microbiol. 2000;37:13-27.
68. Bandi V, Apicella MA, Mason E, et al. Nontypeable Haemophilus infiuenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med. 2001;164:2114-2119.
69. Watanabe T, Jono H, Han J, et al. Synergistic activation of NF-kappaB by nontypeable Haemophilus infiuenzae and tumor necrosis factor alpha. Proc Natl Acad Sci USA. 2004;101:3563-3568.
70. Wang X, Moser C, Louboutin JP, et al. Toll-like receptor 4 mediates innate immune responses to Haemophilus infiuenzae infection in mouse lung. J Immunol. 2002;168:810-815.
71. Berenson CS, Murphy TF, Wrona CT, et al. Outer membrane protein P6 of nontypeable Haemophilus infiuenzae is a potent and selective inducer of human macrophage proinfiammatory cytokines. Infect Immun. 2005;73: 2728-2735.
72. Ratner AJ, Lysenko ES, Paul MN, et al. Synergistic proinfiammatory responses induced by polymicrobial colonization of epithelial surfaces. Proc Natl Acad Sci USA. 2005;102:3429-3434.
73. Chen R, Lim JH, Jono H, et al. Nontypeable Haemophilus infiuenzae lipoprotein P6 induces MUC5AC mucin transcription via TLR2-TAK1-dependent p38 MAPK-AP1 and IKKbeta-IkappaBalpha-NF-kappaB signaling pathways. Biochem Biophys Res Commun. 2004;324:1087-1094.
74. Shuto T, Xu H, Wang B, et al. Activation of NF-kappa B by nontypeable Hemophilus infiuenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc Natl Acad Sci USA. 2001;98: 8774-8779.
75. Pettigrew MM, Foxman B, Marrs CF, et al. Identification of the lipooligo-saccharide biosynthesis gene lic2B as a putative virulence factor in strains of nontypeable Haemophilus infiuenzae that cause otitis media. Infect Immun. 2002;70:3551-3556.
76. Xie J, Juliao PC, Gilsdorf JR, et al. Identification of new genetic regions more prevalent in nontypeable Haemophilus infiuenzae otitis media strains than in throat strains. J Clin Microbiol. 2006;44:4316-4325.
77. Lysenko ES, Ratner AJ, Nelson AL, et al. The role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfaces. PLoS Pathog. 2005;1:e1.
78. Hong W, Mason K, Jurcisek J, et al. Phosphorylcholine decreases early infiammation and promotes the establishment of stable biofilm communities of nontypeable Haemophilus infiuenzae strain 86-028NP in a chinchilla model of otitis media. Infect Immun. 2007;75:958-965.
79. Jurcisek JA, Bakaletz LO. Biofilms formed by nontypeable Haemophilus infiuenzae in vivo contain both dsDNA as well as type IV pilin protein. J Bacteriol. 2007;189:3868-3875.
80. Jurcisek J, Greiner L, Watanabe H, et al. Role of sialic acid and complex carbohydrate biosynthesis in biofilm formation by nontypeable Haemophilus infiuenzae in the chinchilla middle ear. Infect Immun. 2005;73:3210-3218.
81. Ehrlich GD, Veeh R, Wang X, et al. Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. JAMA. 2002; 287:1710-1715.
82. Hall-Stoodley L, Hu FZ, Gieseke A, et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA. 2006;296:202-211.
83. Slinger R, Chan F, Ferris W, et al. Multiple combination antibiotic susceptibility testing of nontypeable Haemophilus infiuenzae biofilms. Diagn Microbiol Infect Dis. 2006;56:247-253.
84. Moxon ER, Sweetman WA, Deadman ME, et al. Haemophilus infiuenzae biofilms: hypothesis or fact? Trends Microbiol. 2008;16:95-100.
85. Murphy TF, Brauer AL, Sethi S, et al. Haemophilus haemolyticus: a human respiratory tract commensal to be distinguished from Haemophilus infiuenzae. J Infect Dis. 2007;195:81-89.
86. Hendolin PH, Paulin L, Ylikoski J. Clinically applicable multiplex PCR for four middle ear pathogens. J Clin Microbiol. 2000;38:125-132.
87. Post JC, Preston RA, Aul JJ, et al. Molecular analysis of bacterial pathogens in otitis media with effusion. JAMA. 1995;273:1598-1604.
88. Rayner MG, Zhang Y, Gorry MC, et al. Evidence of bacterial metabolic activity in culture-negative otitis media with effusion. JAMA. 1998;279: 296-299.
89. Post JC, Aul JJ, White GJ, et al. PCR-based detection of bacterial DNA after antimicrobial treatment is indicative of persistent, viable bacteria in the chinchilla model of otitis media. Am J Otolaryngol. 1996;17:106-111.
90. Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemophilus infiuenzae. Clin Microbiol Rev. 2007;20;368-389.
91. Heilmann KP, Rice CL, Miller AL, et al. Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus in-fiuenzae in the United States. Antimicrob Agents Chemother. 2005;49:2561-2564.
92. Hasegawa K, Chiba N, Kobayashi R, et al. Rapidly increasing prevalence of beta-lactamase-nonproducing, ampicillin-resistant Haemophilus infiuenzae type b in patients with meningitis. Antimicrob Agents Chemother. 2004;48: 1509-1514.
93. Fluit AC, Florijn A, Verhoef J, et al. Susceptibility of European beta-lactamase-positive and -negative Haemophilus infiuenzae isolates from the periods 1997/1998 and 2002/2003. J Antimicrob Chemother. 2005;56:133-138.
94. Garcia-Cobos S, Campos J, Lazaro E, et al. Ampicillin-resistant non-beta-lactamase-producing Haemophilus infiuenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. Anti-microb Agents Chemother. 2007;51:2564-2573.
95. Hotomi M, Fujihara K, Billal DS, et al. Genetic characteristics and clonal dissemination of -lactamase negative ampicillin-resistant Haemophilus infiuenzae strains isolated from the upper respiratory tract in Japan. Antimi-crob Agents Chemother. 2007;51:3969-3976.
96. Little P, Gould C, Williamson I, et al. Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ. 2001; 322:336-342.
97. McCormick DP, Chonmaitree T, Pittman C, et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics. 2005;115:1455-1465.
98. Dagan R, Leibovitz E, Greenberg D, et al. Early eradication of pathogens from middle ear fiuid during antibiotic treatment of acute otitis media is associated with improved clinical outcome. Pediatr Infect Dis J. 1998;17: 776-782.
99. Leach AJ, Morris PS. Antibiotics for the prevention of acute and chronic suppurative otitis media in children. Cochrane Database Syst Rev. 2006: CD004401.00
100. Prymula R, Peeters P, Chrobok V, et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus infiuenzae: a randomised double-blind efficacy study. Lancet. 2006;367:740-748.01
101. Forsgren A, Riesbeck K, Janson H. Protein D of Haemophilus infiuenzae:a protective nontypeable Haemophilus infiuenzae antigen and a carrier for pneumo-coccal conjugate vaccines. Clin Infect Dis. 2008;46:726-731.02
102. Novotny LA, Jurcisek JA, Godfroid F, et al. Passive immunization with human anti-protein D antibodies induced by polysaccharide protein D conjugates protects chinchillas against otitis media after intranasal challenge with Haemophilus infiuenzae. Vaccine. 2006;24:4804-4811.03
103. Murphy TF, Bakaletz LO, Kyd JM, et al. Vaccines for otitis media: proposals for overcoming obstacles to progress. Vaccine. 2005;23:2696-2702.04
104. Giebink GS, Kurono Y, Bakaletz LO, et al. Recent advances in otitis media. 6. Vaccine. Ann Otol Rhinol Laryngol Suppl. 2005;194:86-103.